Fig. 2.

NIT scores distributions by age and at-risk MASH status.

∗y-axis on a log10 scale for improved representations. Matched cohort, n = 708. At-risk MASH was defined as MASH with MAS ≥4 and F ≥2. ALT, alanine aminotransferase; APRI, aspartate aminotransferase-to-platelet ratio index; ELF™, Enhanced Liver Fibrosis; FIB-4, Fibrosis-4; MAS, MASLD activity score; MASH, metabolic dysfunction-associated steatohepatitis; MASLD, metabolic dysfunction-associated liver disease; NAFLD, non-alcoholic fatty liver disease; NFS, NAFLD fibrosis score; NIT, non-invasive test.